Which company's drugs are brigatinib and brigatinib?
Brigatinib and brigatinib are actually the same drug, the English name is Brigatinib, but there are differences in Chinese translation. "Brigatinib" is the more common translation, while "Brigatinib" is another way of transliteration. The two are exactly the same in terms of drug ingredients, indications, usage, etc., and they belong to the same drug. In medical literature, drug registration information and clinical use, the two are usually used interchangeably, and patients do not need to worry about confusion.
Brigatinib (Brigatinib/Brigatinib) is a drug developed by Regeneron Pharmaceuticals of the United States (formerlyAriad Pharmaceuticals, later acquired byTakedaTakeda Pharmaceuticals) ALK (anaplastic lymphoma kinase) inhibitor. It is mainly used to treat patients with ALK-positive metastatic non-small cell lung cancer (NSCLC), especially in patients who are resistant to or have progressed to crizotinib (Crizotinib) and has shown good efficacy. As a second-generation ALK inhibitor, it is superior to some early drugs in terms of brain metastasis control and progression-free survival.

Brigatinib has been approved for marketing in many countries and regions, including China, the United States, the European Union, etc., and is included in medical insurance in China. Its Chinese trade name in China is "Brigatinib Tablets", and Takeda Pharmaceutical is responsible for sales and distribution in the Chinese market. It is officially named "brigatinib" in the instructions approved by China's National Food and Drug Administration (NMPA), which is also the name uniformly used in drug labels and medical insurance catalogs.
Generally speaking,"Brigatinib" and "Brigatinib" are just different in transliteration, they are actually the same drug, namelyBrigatinib. This situation is not uncommon in the field of pharmaceuticals, such as dabrafenib (Dabrafenib), which is sometimes called "dabifenib". For patients and medical staff, they only need to pay attention to the English drug name or specific drug ingredients to avoid confusion and ensure safe and correct medication use.
Reference materials:https://www.alunbrig.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)